Clinical Trial Search

Primary: Percentage of Eligible (Not Known HIV+) New FP Clients Who Are Tested for HIV in the Months 9-12 of the Study in Intervention and Control Facilities — 42; 32 Percentage…

Primary: Change in Proteinuria by 25% — 8 Participants

Primary: Subjective Description of DIR1, DIR2, and DIR3 in Controlled Soft Noise Environment — 40.31; 55.94; 66.88 units on a scale — p=0.004

Primary: Incidence of Postoperative Residual Neuromuscular Blockade at Time of Arrival to the Post-anesthesia Care Unit. — 5 Participants

Primary: The Accuracy of FDOPA PET to Identify Focal Forms of Hyperinsulinism — 40; 6; 3; 46 Participants

Primary: Daytime Ambulatory Systolic Blood Pressure — 123.6; 128.3 millimeters of mercury (mmHg)

Primary: Progression-free Survival (PFS) Per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as Assessed by Blinded Independent Central Review (BICR) — 6.1…

Primary: Number of Subjects With Loss of Therapeutic Response to Levoketoconazole Upon Withdrawing to Placebo Compared With the Proportion of Subjects With Loss of Therapeutic…

Primary: Change From Baseline of HbA1C (Glycated Hemoglobin) — -0.13; -0.60; -0.59; -0.51 percent HbA1C

Primary: Number of Participants With Toxicities That Required the Addition of Prednisone to Manage Symptoms of Persistent or Severe Mineralocorticoid Excess — 38; 28; 15; 11…

Primary: The Mean Time Normalized Number of HAE Attacks Per Month in Subjects With C1-INH HAE During Treatment Period 1 — 4.24; 0.48; 0.05; 0.35 Number of HAE attacks per month

Primary: Percentage of Patients Free of Grade 3+ Late Toxicity — 86 percentage of participants

Primary: Number of Adverse Events, Graded According to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) v4.0 — 56 Adverse Events

Primary: Human Factors - User Performance in Use Scenarios Assessment With Observer Ratings — 15; 0; 14; 1 Participants

Primary: Post-operative Urinary Tract Infection — 19; 20 Participants